Year |
Citation |
Score |
2019 |
Panjarian S, Madzo J, Slater C, Jelinek J, Chen X, Issa J. Abstract P3-05-03: Identification of epigenetically silenced breast cancer driver genes Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P3-05-03 |
0.302 |
|
2018 |
Good CR, Panjarian S, Kelly AD, Madzo J, Patel B, Jelinek J, Issa JJ. TET1-mediated hypomethylation activates oncogenic signaling in triple-negative breast cancer. Cancer Research. PMID 29891505 DOI: 10.1158/0008-5472.Can-17-2082 |
0.359 |
|
2016 |
Sato T, Cesaroni M, Chung W, Panjarian S, Tran A, Madzo J, Okamoto Y, Zhang H, Chen X, Jelinek J, Issa JJ. Transcriptional Selectivity of Epigenetic Therapy in Cancer. Cancer Research. PMID 27879268 DOI: 10.1158/0008-5472.Can-16-0834 |
0.348 |
|
2016 |
Badger J, Grover P, Panjarian SB, Engen JR, Smithgall TE, Makowski L. The c-Abl Tyrosine Kinase Adopts Multiple Active Conformational States in Solution. Biochemistry. PMID 27166638 DOI: 10.1021/Acs.Biochem.6B00202 |
0.706 |
|
2016 |
Sato T, Cesaroni M, Tran A, Madzo J, Okamoto Y, Zhang H, Panjarian S, Jelinek J, Issa J. Abstract B42: Decitabine specifically targets genes that gain DNA methylation and lose expression in cancer and can be combined with histone methylation inhibitors for increased efficacy Cancer Research. 76. DOI: 10.1158/1538-7445.Chromepi15-B42 |
0.34 |
|
2016 |
Sato T, Cesaroni M, Panjarian S, Tran A, Madzo J, Okamoto Y, Zhang H, Chen X, Jelinek J, Issa JJ. Abstract 2657: Target specificity of epigenetic therapy in cancer Cancer Research. 76: 2657-2657. DOI: 10.1158/1538-7445.Am2016-2657 |
0.335 |
|
2013 |
Panjarian S, Iacob RE, Chen S, Engen JR, Smithgall TE. Structure and dynamic regulation of Abl kinases. The Journal of Biological Chemistry. 288: 5443-50. PMID 23316053 DOI: 10.1074/Jbc.R112.438382 |
0.675 |
|
2013 |
Panjarian S, Iacob RE, Chen S, Wales TE, Engen JR, Smithgall TE. Enhanced SH3/linker interaction overcomes Abl kinase activation by gatekeeper and myristic acid binding pocket mutations and increases sensitivity to small molecule inhibitors. The Journal of Biological Chemistry. 288: 6116-29. PMID 23303187 DOI: 10.1074/Jbc.M112.431312 |
0.713 |
|
2013 |
Panjarian SB, Iacob R, Shugui C, Wales T, Engen JR, Smithgall TE. Abstract 2221: Enhanced SH3:linker interaction allosterically sensitizes Abl kinases to small molecule inhibitors. Cancer Research. 73: 2221-2221. DOI: 10.1158/1538-7445.Am2013-2221 |
0.723 |
|
2012 |
Panjarian SB, Chen S, Iacob R, Wales T, Engen JR, Smithgall TE. Abstract 5599: Allosteric regulation of Abl and Bcr-Abl kinases by enhanced SH3:linker interaction Cancer Research. 72: 5599-5599. DOI: 10.1158/1538-7445.Am2012-5599 |
0.734 |
|
2011 |
Panjarian SB, Chen S, Iacob R, Wales TE, Engen JR, Smithgall TE. Abstract B75: Allosteric regulation of Abl and Bcr-Abl kinases by enhanced SH3:linker interaction. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B75 |
0.738 |
|
2010 |
Panjarian S, Chen S, Engen J, Smithgall T. Enhanced SH3:Linker Interaction Suppresses Activating Mutations of the c-Abl Protein-Tyrosine Kinase. Blood. 116: 1208-1208. DOI: 10.1182/Blood.V116.21.1208.1208 |
0.712 |
|
2010 |
Panjarian S, Smithgall TE. Abstract 632: Cross-resistance of myeloid cells transformed with Bcr-Abl imatinib-resistant mutant T315I to Src-family kinase inhibitors Cancer Research. 70: 632-632. DOI: 10.1158/1538-7445.Am10-632 |
0.612 |
|
2009 |
Choi Y, Seeliger MA, Panjarian SB, Kim H, Deng X, Sim T, Couch B, Koleske AJ, Smithgall TE, Gray NS. N-myristoylated c-Abl tyrosine kinase localizes to the endoplasmic reticulum upon binding to an allosteric inhibitor. The Journal of Biological Chemistry. 284: 29005-14. PMID 19679652 DOI: 10.1074/Jbc.M109.026633 |
0.694 |
|
2008 |
Panjarian S, Kozhaya L, Arayssi S, Yehia M, Bielawski J, Bielawska A, Usta J, Hannun YA, Obeid LM, Dbaibo GS. De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation. Prostaglandins & Other Lipid Mediators. 86: 41-8. PMID 18400537 DOI: 10.1016/J.Prostaglandins.2008.02.004 |
0.355 |
|
2003 |
El-Assaad W, Kozhaya L, Araysi S, Panjarian S, Bitar FF, Baz E, El-Sabban ME, Dbaibo GS. Ceramide and glutathione define two independently regulated pathways of cell death initiated by p53 in Molt-4 leukaemia cells. Biochemical Journal. 376: 725-732. PMID 12967322 DOI: 10.1042/Bj20030888 |
0.31 |
|
Show low-probability matches. |